Strategic Healthcare Alliance

What Strategic Healthcare Alliance does

Strategic Healthcare Alliance (SHA), doing business as SHA, is a private healthcare communications and consulting firm headquartered at 100 Lanidex Plaza, Suite 140, Parsippany, NJ. Founded in 2006 and operating as Strategic Healthcare Alliance, LLC, the company serves pharmaceutical, biotechnology, and medical device manufacturers with market access and reimbursement strategy consulting, helping clients secure formulary coverage, optimize payer relationships, and differentiate products in competitive therapeutic categories. Its documented therapeutic-area experience spans respiratory, cardiovascular, metabolic, musculoskeletal, neurologic, oncologic, rare and ultra-rare diseases, viral/infection, and medical devices.

The company's core technology is a proprietary database of thousands of managed care key opinion leaders (KOLs) across national and regional health plans, supplemented by a payer decision-maker database and a proprietary formulary coverage assessment system. These data assets are wrapped in the SHA Program Development Process, a proprietary methodology that guides payer-focused program design and omni-channel execution (symposia, white papers, slide decks, web portals) across the full product lifecycle. Case-study outcomes referenced by the company include improving a client's managed care ranking from #18 to #3 within one year and achieving category market leadership within nine months of an antiobesity product launch.

SHA operates a sales-led, enterprise B2B go-to-market with no self-service or channel-partner distribution. Pricing is custom and project-based under multi-year contracts, and the company does not publicly disclose pricing or revenue. The firm employs 11–50 people, with no disclosed external investors, funding rounds, or ownership structure beyond its New Jersey LLC formation.

Name

Strategic Healthcare Alliance

Legal name

Strategic Healthcare Alliance, LLC

Website

https://shalliance.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Strategic Healthcare Alliance is a Parsippany, NJ-based B2B healthcare communications firm that provides market access and reimbursement strategy consulting to pharmaceutical, biotech, and medical device manufacturers, supported by a proprietary managed-care KOL database.

Ownership category

akta.pro rank

Product category

Healthcare Market Access Consulting

NAICS

Advertising, Public Relations, and Related Services (5418)

SIC

Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYMPAAADAD

Healthcare & Life Sciences PR

Media, Entertainment & Sports/Advertising, Marketing & PR Services/Public Relations & Communications Agencies

SECONDARYHLAGALAM

KOL Engagement & Medical Education (Advisory Boards/CME Support)

Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Pharmacovigilance & Medical Affairs Services

Keywords

• Market access consulting
• Reimbursement strategy
• Healthcare communications
• Managed markets strategy
• Pharmaceutical payer marketing

Headquarters

HQ city

Lyndhurst

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Others

Revenue model

1. Professional Services - Market Access Consulting: SHA provides full-service healthcare communications specializing in market access and reimbursement strategies. The company assists pharmaceutical, biotech, and device manufacturers with aligning stakeholder needs with organizational offerings. Services include strategy development, message and tool creation, payer relationship building, and omni-channel offerings across the product lifecycle.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Strategic Healthcare Alliance is a full-service healthcare communications company that provides market access and reimbursement strategy services to pharmaceutical, biotechnology, and medical device manufacturers. Its core offering combines a proprietary SHA Program Development Process with a proprietary Key Opinion Leader (KOL) Database of managed care professionals, omni-channel payer communications (symposia, white papers, slide decks, web portals), and disease management programs that span the product lifecycle across numerous therapeutic areas including rare and ultra-rare diseases.

Product overview

Strategic Healthcare Alliance (SHA) is a full-service healthcare communications company offering a unified suite of services centered on market access and reimbursement strategies for pharmaceutical, biotech, and device manufacturers. The core offering comprises SHA's Program Development Process—a proprietary methodology for payer-focused program development—supplemented by its KOL Database of managed care professionals, omni-channel marketing services (including symposia, white papers, slide decks, and web portals), and disease management programs. These integrated services work together to help clients differentiate in competitive marketplaces, optimize reimbursement, and build partnerships beyond product offerings alone.

Differentiator

Problem solved

Functional benefit

Products and services

• Market Access and Reimbursement Strategies Strategic consulting services that help pharmaceutical, biotech, and device manufacturers navigate payer coverage decisions, formulary placement, and reimbursement optimization across US and global markets. The offering is intended for manufacturer brand, market access, and managed markets teams seeking differentiated positioning in competitive therapeutic categories.
• SHA Program Development Process A proprietary methodology for developing payer-focused programs that guides clients through market access strategy, stakeholder alignment, and initiative execution across the product lifecycle. It is sold as part of SHA's core professional services engagement for pharmaceutical, biotech, and device manufacturers.
• KOL Database A proprietary database of thousands of managed care professionals including national and regional health plan representatives and non-traditional stakeholders, used to enable rapid surveying on emerging business trends and payer engagement. The asset supports SHA's payer-focused engagements for manufacturer clients.
• Omni-Channel Marketing Services Multi-channel communication offerings including symposia, white papers, slide decks, and web portals that connect manufacturers with payer decision makers through business-to-business approaches. Designed for manufacturer account managers and market access teams that need to reach pharmacy directors, medical directors, and C-suite executives at health plans.
• Disease Management Programs Custom programs developed for specialty pharmacy providers and managed care organizations to increase patient engagement and adherence, leveraging existing client assets and interactive digital platforms. Targeted at manufacturers seeking to improve adherence, quality, and stakeholder outcomes in partnership with payers and specialty pharmacies.

Quantifiable outcome

• Client ranking among pharmaceutical companies improved from #18 to #3 in managed care plan surveys after 1 year of SHA engagement
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• Beghou Consulting: Beghou Consulting is a boutique life sciences consultancy focused on commercial strategy, market access, and analytics for pharma and biotech. Directly comparable to SHA in market access advisory and managed markets execution for emerging biopharma clients.
• Triangle Insights Group: Triangle Insights Group is a boutique consultancy providing commercial strategy, market access, and launch planning to biopharmaceutical clients. Directly comparable to SHA in addressing payer stakeholders and reimbursement positioning.
• Defined Health: Defined Health is a strategic commercial consultancy serving biopharma clients with market access, therapeutic area strategy, and product launch support. Directly comparable to SHA's payer-focused market access work, particularly for specialty and rare disease launches.
• Real Chemistry: Real Chemistry is a healthcare marketing and communications firm serving pharma, biotech, and consumer health clients, with a strong market access and data offering. Comparable to SHA in payer communications and managed markets engagement.
• ZS Associates: ZS Associates is a leading global consultancy specializing in market access, sales, and marketing for pharmaceutical and biotech clients. Directly comparable to SHA in market access strategy and payer engagement, though at much larger scale.
• Cello Health (now part of Ashfield): Cello Health offered strategic commercial, market access, and medical communications services to pharma clients. Directly comparable to SHA in payer communications, value communications, and market access strategy.
• Dudnyk (now part of Bioscience Communications): Dudnyk was a specialty pharma advertising and communications agency focused on market access and payer engagement. Directly comparable to SHA in healthcare communications and payer-facing creative.

Broad incumbents

• IQVIA: IQVIA is a large global life sciences services and analytics firm with extensive market access, payer evidence, and commercialization offerings. Overlaps with SHA's market access and reimbursement work as part of a much broader portfolio.
• Syneos Health: Syneos Health is a biopharmaceutical solutions organization offering commercialization, market access, and communications services. Comparable to SHA in payer and managed markets communications within a broader clinical and commercial portfolio.
• McKinsey & Company (Pharma Practice): McKinsey's Pharmaceuticals & Medical Products practice offers market access, pricing, and reimbursement consulting to large pharma manufacturers. Overlaps with SHA in market access strategy as part of a broader general management consulting practice.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/strategic-healthcare-alliance

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Strategic Healthcare Alliance